Regadenoson 68083-0175
Product NDC
68083-0175- Manufacturer
- Gland Pharma Limited
- Dosage Form
- Injection, Solution
- Route
- Intravenous
- Product Type
- Human Prescription Drug
- Marketing Start
- July 12, 2022
- Listing Expires
- December 31, 2026
- Application
- ANDA207320
Need to source Regadenoson? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Regadenoson | .08 mg/mL |
Drug Class
Adenosine Receptor Agonist [EPC]Adenosine Receptor Agonists [MoA]Pharmacologic Cardiac Stress Test Agent [EPC]
Packaging Options(1)
10 VIAL in 1 CARTON (68083-175-10) / 5 mL in 1 VIAL (68083-175-01)